DE68905117T2 - Verfahren zur stabilisierung von blutgewinnungsfaktoren. - Google Patents

Verfahren zur stabilisierung von blutgewinnungsfaktoren.

Info

Publication number
DE68905117T2
DE68905117T2 DE8989116866T DE68905117T DE68905117T2 DE 68905117 T2 DE68905117 T2 DE 68905117T2 DE 8989116866 T DE8989116866 T DE 8989116866T DE 68905117 T DE68905117 T DE 68905117T DE 68905117 T2 DE68905117 T2 DE 68905117T2
Authority
DE
Germany
Prior art keywords
stabilizing blood
generation factors
blood generation
factors
stabilizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989116866T
Other languages
English (en)
Other versions
DE68905117D1 (de
Inventor
Masayasu Enomoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shoji Co Ltd
Original Assignee
Nippon Shoji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shoji Co Ltd filed Critical Nippon Shoji Co Ltd
Application granted granted Critical
Publication of DE68905117D1 publication Critical patent/DE68905117D1/de
Publication of DE68905117T2 publication Critical patent/DE68905117T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving
DE8989116866T 1988-09-12 1989-09-12 Verfahren zur stabilisierung von blutgewinnungsfaktoren. Expired - Lifetime DE68905117T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63227940A JPH0650999B2 (ja) 1988-09-12 1988-09-12 血液凝固因子安定化法

Publications (2)

Publication Number Publication Date
DE68905117D1 DE68905117D1 (de) 1993-04-08
DE68905117T2 true DE68905117T2 (de) 1993-08-05

Family

ID=16868667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989116866T Expired - Lifetime DE68905117T2 (de) 1988-09-12 1989-09-12 Verfahren zur stabilisierung von blutgewinnungsfaktoren.

Country Status (8)

Country Link
US (1) US5147803A (de)
EP (1) EP0359201B1 (de)
JP (1) JPH0650999B2 (de)
DE (1) DE68905117T2 (de)
DK (1) DK447489A (de)
ES (1) ES2053897T3 (de)
FI (1) FI93494C (de)
NO (1) NO178682C (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650999B2 (ja) * 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法
CA2080428C (en) * 1991-10-22 2004-01-27 Ray F. Ebert A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test
JPH08224227A (ja) * 1995-02-22 1996-09-03 Internatl Reagents Corp 血液採血管
DE59702207D1 (de) * 1996-03-08 2000-09-21 Octapharma Ag Lachen Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
DE19858278A1 (de) * 1998-12-17 2000-06-21 Dade Behring Marburg Gmbh Verfahren zum Lokalisieren von Defekten im Gerinnungssystem
AU7137900A (en) * 1999-07-23 2001-02-13 Medical Analysis Systems, Inc. Stabilized coagulation control reagent and method of making same
US6586574B1 (en) 1999-08-17 2003-07-01 Nn A/S Stabilization of freeze-dried cake
WO2001012653A1 (en) * 1999-08-17 2001-02-22 Novo Nordisk A/S Stabilisation of freeze-dried cake
US6248353B1 (en) 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6465202B1 (en) * 2000-02-17 2002-10-15 Biosafe Laboratories, Inc. Method for stabilizing aminotransferase activity in a biological fluid
GB0305133D0 (en) * 2003-03-06 2003-04-09 Sinvent As Product
EP2405275B1 (de) 2009-03-05 2018-10-10 BML, Inc. Messmethode für glykosyliertes Albumin in Serum oder Plasma unter Verwendung von Mannitol als Stabilisator für das Kontrollserum oder -plasma.
WO2012173260A1 (ja) 2011-06-17 2012-12-20 学校法人東日本学園・北海道医療大学 ループスアンチコアグラント検出用血液凝固時間の測定方法
CA2839117C (en) 2011-06-17 2019-09-17 School Juridical Person Higashi-Nippon-Gakuen Method for detecting lupus anticoagulants
JP6116231B2 (ja) * 2012-12-25 2017-04-19 株式会社Ｌｓｉメディエンス 組織トロンボプラスチン含有血液凝固能測定試薬及び測定方法
US20170202211A1 (en) * 2014-06-10 2017-07-20 Biomatrica, Inc. Stabilization of Metabolically-Active Cells in a Blood Sample at Ambient Temperatures
JP6661554B2 (ja) 2014-06-10 2020-03-11 バイオマトリカ，インク． 周囲温度における血小板の安定化
CN104181313B (zh) * 2014-09-04 2015-11-18 中国医学科学院输血研究所 凝血因子ⅸ质控品制备方法
CN105353141B (zh) * 2015-11-17 2018-04-10 北京美创新跃医疗器械有限公司 检测试剂及其应用及含有该试剂的试剂盒
SG11201804776SA (en) 2015-12-08 2018-07-30 Biomatrica Inc Reduction of erythrocyte sedimentation rate
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
JP2022525398A (ja) 2019-03-14 2022-05-13 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥容器用充填治具、システム及び使用方法
JP7473282B1 (ja) * 2022-10-14 2024-04-23 積水メディカル株式会社 凝固第ｘｉｉ因子欠乏血液検体の血液凝固時間短縮剤
WO2024080373A1 (ja) * 2022-10-14 2024-04-18 積水メディカル株式会社 活性化部分トロンボプラスチン時間測定のための試薬、及びループスアンチコアグラント陽性血液検体又はヘパリン含有血液検体の血液凝固時間調節剤
WO2024080372A1 (ja) * 2022-10-14 2024-04-18 積水メディカル株式会社 凝固第ｖｉｉｉ、ｉｘ又はｘｉ因子欠乏血液検体の血液凝固時間調節剤、及び活性化部分トロンボプラスチン時間測定のための試薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL275394A (de) * 1961-02-28
US3323995A (en) * 1963-05-20 1967-06-06 Univ Northwestern Method of inhibiting the crosslinking of fibrin in blood
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
US4271122A (en) * 1978-04-27 1981-06-02 Hoffmann-La Roche Inc. Control plasma
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
JPS57112367A (en) * 1980-12-29 1982-07-13 Sankyo Co Ltd Preparation of stable aqueous solution of compound having thiol group
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
JPS59192961A (ja) * 1983-04-15 1984-11-01 Green Cross Corp:The 血液凝固第「じ」因子測定用試薬
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
JPH0650999B2 (ja) * 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法

Also Published As

Publication number Publication date
ES2053897T3 (es) 1994-08-01
JPH0650999B2 (ja) 1994-07-06
FI894303A (fi) 1990-03-13
DK447489A (da) 1990-03-13
NO893637D0 (no) 1989-09-11
NO178682B (no) 1996-02-05
JPH0275953A (ja) 1990-03-15
NO178682C (no) 1996-05-15
FI93494C (fi) 1995-04-10
EP0359201A3 (de) 1991-01-09
FI894303A0 (fi) 1989-09-12
EP0359201A2 (de) 1990-03-21
US5147803A (en) 1992-09-15
FI93494B (fi) 1994-12-30
DE68905117D1 (de) 1993-04-08
NO893637L (no) 1990-03-13
DK447489D0 (da) 1989-09-11
EP0359201B1 (de) 1993-03-03

Similar Documents

Publication Publication Date Title
DE68905117D1 (de) Verfahren zur stabilisierung von blutgewinnungsfaktoren.
DE68910941D1 (de) Verfahren zur herstellung von hydroxylapatit.
DE68907258D1 (de) Verfahren zur herstellung von perfluorierten copolymeren.
DE68908193D1 (de) Verfahren zur herstellung von fluorglimmer.
DE58901598D1 (de) Verfahren zur gewinnung von rohargon.
DE68918083T2 (de) Verfahren zur reinigung von blutplasma.
DE68901908T2 (de) Verfahren zur herstellung von mesophasepech.
DE68918601T2 (de) Verfahren zur herstellung von ortho-nitrobenzonitrilen.
DE68904436T2 (de) Verfahren zur herstellung von 1-alkyl-5-nitro-imidazolen.
DE58902073D1 (de) Verfahren zur herstellung von organohalogensilanen.
DE3874510T2 (de) Verfahren zur stabilisierung von hydroisomeraten.
DE68905908D1 (de) Verfahren zur herstellung von alkansulfonamiden.
DE68906638T2 (de) Verfahren zur herstellung von 4-methylpyrazolen.
DE58901624D1 (de) Verfahren zur herstellung von fluorbenzolen.
DE58900652D1 (de) Verfahren zur aufarbeitung von verbrauchten beizbaedern.
DE58900894D1 (de) Verfahren zur gewinnung von gallium.
DE68907097D1 (de) Verfahren zur herstellung von ketodiestern.
DE58902083D1 (de) Verfahren zur herstellung von dihydroxydionen.
DE68903517T2 (de) Verfahren zur herstellung von acylisocyanaten.
DE68905175D1 (de) Verfahren zur stabilisierung von zyklischen carbonaten.
DE3770602D1 (de) Verfahren zur beseitigung von abraum.
DE68904748D1 (de) Verfahren zur herstellung von p-isobutylstyrol.
DE68916044T2 (de) Verfahren zur Chlordephenylierung von Phenylsilanen.
DE68907972D1 (de) Verfahren zur herstellung von l-arginin.
DE68905673D1 (de) Verfahren zur ausscheidung von 2,6-dimethylnaphthalin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee